These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8397007)

  • 1. Membrane function and vascular reactivity.
    Bing RJ; Termin A; Conforto A; Dudek R; Hoffmann MJ
    Biosci Rep; 1993 Apr; 13(2):61-7. PubMed ID: 8397007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ERK1/2 activation and nNOS uncoupling on endothelial dysfunction induced by lysophosphatidylcholine.
    Campos-Mota GP; Navia-Pelaez JM; Araujo-Souza JC; Stergiopulos N; Capettini LSA
    Atherosclerosis; 2017 Mar; 258():108-118. PubMed ID: 28235709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular translocation of endothelial nitric oxide synthase by lysophosphatidylcholine.
    Dudek R; Wildhirt S; Suzuki H; Winder S; Bing RJ
    Pharmacology; 1995 Apr; 50(4):257-60. PubMed ID: 7540765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidylcholine and 7-oxocholesterol modulate Ca2+ signals and inhibit the phosphorylation of endothelial NO synthase and cytosolic phospholipase A2.
    Millanvoye-Van Brussel E; Topal G; Brunet A; Do Pham T; Deckert V; Rendu F; David-Dufilho M
    Biochem J; 2004 Jun; 380(Pt 2):533-9. PubMed ID: 14992685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E inhibits lysophosphatidylcholine-induced endothelial dysfunction and platelet activation.
    Murohara T; Ikeda H; Katoh A; Takajo Y; Otsuka Y; Haramaki N; Imaizumi T
    Antioxid Redox Signal; 2002 Oct; 4(5):791-8. PubMed ID: 12470507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pravastatin on impaired endothelium-dependent relaxation induced by lysophosphatidylcholine in rat aorta.
    Deng HF; Xiong Y
    Acta Pharmacol Sin; 2005 Jan; 26(1):92-8. PubMed ID: 15659120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidylcholine modifies G protein-dependent signaling in porcine endothelial cells.
    Flavahan NA
    Am J Physiol; 1993 Mar; 264(3 Pt 2):H722-7. PubMed ID: 8456975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oleoyl-lysophosphatidylcholine limits endothelial nitric oxide bioavailability by induction of reactive oxygen species.
    Kozina A; Opresnik S; Wong MS; Hallström S; Graier WF; Malli R; Schröder K; Schmidt K; Frank S
    PLoS One; 2014; 9(11):e113443. PubMed ID: 25419657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of daviditin A against endothelial damage induced by lysophosphatidylcholine.
    Jiang DJ; Jiang JL; Tan GS; Du YH; Xu KP; Li YJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):600-6. PubMed ID: 12750878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LPC in oxidized LDL elicits vasocontraction and inhibits endothelium- dependent relaxation.
    Murohara T; Kugiyama K; Ohgushi M; Sugiyama S; Ohta Y; Yasue H
    Am J Physiol; 1994 Dec; 267(6 Pt 2):H2441-9. PubMed ID: 7810742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M; Liu L; Guo Z; Xiong Y
    Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of endothelium-dependent vasorelaxation to lysophosphatidylcholine.
    Hirayama T; Ogawa Y; Tobise K; Onodera S
    Jpn J Pharmacol; 1992; 58 Suppl 2():391P. PubMed ID: 1324363
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of endothelial nitric oxide in the regulation of the vasomotor system].
    Michel JB
    Pathol Biol (Paris); 1998 Mar; 46(3):181-9. PubMed ID: 9769914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of amphiphiles on nitric oxide synthase in endothelial cells.
    Dudek R; Conforto A; Pinto V; Bing RJ
    Pharmacology; 1994 Jun; 48(6):374-9. PubMed ID: 7519349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysolecithins as endothelium-dependent vascular smooth muscle relaxants that differ from endothelium-derived relaxing factor (nitric oxide).
    Saito T; Wolf A; Menon NK; Saeed M; Alves C; Bing RJ
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8246-50. PubMed ID: 3263649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.
    Gupta S; Wright HM
    Cardiovasc Ther; 2008; 26(3):189-202. PubMed ID: 18786089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis.
    Kougias P; Chai H; Lin PH; Lumsden AB; Yao Q; Chen C
    Med Sci Monit; 2006 Jan; 12(1):RA5-16. PubMed ID: 16369478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transactivation of fetal liver kinase-1/kinase-insert domain-containing receptor by lysophosphatidylcholine induces vascular endothelial cell proliferation.
    Fujita Y; Yoshizumi M; Izawa Y; Ali N; Ohnishi H; Kanematsu Y; Ishizawa K; Tsuchiya K; Tamaki T
    Endocrinology; 2006 Mar; 147(3):1377-85. PubMed ID: 16322069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for selective inhibition by lysophosphatidylcholine of acetylcholine-induced endothelium-dependent hyperpolarization and relaxation in rat mesenteric artery.
    Fukao M; Hattori Y; Kanno M; Sakuma I; Kitabatake A
    Br J Pharmacol; 1995 Sep; 116(1):1541-3. PubMed ID: 8564216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary n-3 polyunsaturated fatty acids and endothelium dysfunction induced by lysophosphatidylcholine in Syrian hamster aorta.
    Lucas A; Grynberg A; Lacour B; Goirand F
    Metabolism; 2008 Feb; 57(2):233-40. PubMed ID: 18191054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.